UPDATE: Exxon 1Q Profit Misses Views On Health Charge, Weak Refining
April 29 2010 - 9:34AM
Dow Jones News
Exxon Mobil Corp.'s (XOM) first-quarter earnings rose 38% but
fell short of analysts' expectations, in part due to a $200 million
charge tied to U.S. health care legislation.
The Irving, Texas-based company's profits have disappointed in
three of the last four quarters, as the company's refining division
has seen profit margins pressured by rising oil prices and weak
fuel demand.
Exxon also generated more revenue from natural gas production
than anticipated, even as global gas prices fell short of
expectations, noted analysts with Credit Suisse. Higher margins in
the company's chemicals division "saved" first-quarter earnings,
but BP PLC (BP) said recently that "margins have since turned down
in this area," the analysts added.
In the first quarter, the company saw corporate expenses rise by
$364 million from a year earlier, largely due to higher health-care
costs stemming from U.S. reform legislation passed last month. Many
companies have reported large one-time charges since President
Barack Obama signed health-care reform into law in March, citing
higher costs related to retiree prescription-drug benefits.
Exxon, the world's biggest non-governmental oil company,
reported a profit of $6.3 billion, or $1.33 a share, up from $4.55
billion, or 92 cents a share, a year earlier. The analysts'
consensus was for earnings of $1.41 a share, according to a Thomson
Reuters poll.
Exxon shares were recently down 1.1% at $68.45.
While Exxon isn't alone in seeing reduced profits from refining,
two of the company's European rivals, BP and Royal Dutch Shell PLC
(RDSB.LN), both topped analysts' expectations when they reported
earnings earlier this month.
Revenue increased 41% to $90.25 billion, below the $96.41
million consensus estimate from Thomson Reuters.
Global oil and gas production, measured in oil-equivalent, rose
4.5% from the first quarter of 2009, with segment earnings more
than doubling as oil prices surged from close to a five-year low
early last year.
Refining earnings tumbled to $37 million from $1.1 billion on
lower margins. Sales also fell on reduced demand.
Exxon said it spent $2.5 billion in the quarter buying back 37
million shares, helping cut the amount of outstanding shares by
0.6%.
The company expects to close its deal for XTO Energy Inc. (XOM)
in the current quarter, leading a rush among international oil
titans to tap U.S. shale-gas resources for future growth.
-By Brian Baskin, Dow Jones Newswires; 212-416-2453;
brian.baskin@dowjones.com
(Tess Stynes and Kevin Kingsbury contributed to this
article.)
XTO (NYSE:XTO)
Historical Stock Chart
From Nov 2024 to Dec 2024
XTO (NYSE:XTO)
Historical Stock Chart
From Dec 2023 to Dec 2024